Carcinoma, Non-Small-Cell Lung × sargramostim × Clear all PNeoVCA
Phase 1/2 Recruiting
132 enrolled
UV1-hTERT2012L
Phase 1/2 Completed
18 enrolled
LUNGVAC
Phase 2 Recruiting
138 enrolled
Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
Phase 2 Completed
8 enrolled 5 charts
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
Phase 1 Completed
60 enrolled
CRAGMOLC
Phase NA Unknown
45 enrolled
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
Phase 1 Completed
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Phase 2 Completed
12 enrolled
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Phase 1 Completed
22 enrolled 7 charts
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer
Phase 1 Terminated
5 enrolled
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
Phase 1 Terminated
60 enrolled
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Phase 2 Completed
40 enrolled
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
Phase 1 Completed
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
Phase 2 Completed
24 enrolled
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled